Based on the comprehensive data, here's what I'm seeing for CVX:

Based on the comprehensive data, here's what I'm seeing for CVX:

Current Snapshot (April 21, 2026)

Price & Performance:

• Close: $185.98
• 1-day: +1.49%
• 1-week: -0.56%
• 1-month: -7.81%
• YTD: +22.03%

Market Cap: $370.5 billion

Short Interest:

• SI % of Free Float: 1.11% (20.6M shares)
• Days to Cover: 0.58 days (very low)
• Recent trend: Down significantly from 1.40% on March 24
• Short interest has declined about 20% since late March

Cost to Borrow: 0.35% (very low - easy to short)

Utilization: 0.45% (extremely low - lots of shares available to borrow)

Options Sentiment:

• Put/Call Ratio: 0.79 (slightly elevated vs 20-day mean of 0.78)
• PCR is near the middle of its 52-week range (0.60-0.93)

ORTEX Scores:

• Total Stock Score: 76.95 (strong)
• Short Score: 28.73 (low short pressure)

Technicals:

• RSI-14: 41.58 (approaching oversold territory)

Analyst Outlook:

• Return Potential: +14.01% to consensus target
• Dividend Yield: 3.94%

Next Event: Q1 2026 Earnings Call on May 1, 2026

Key Takeaways

CVX shows minimal short interest pressure with just 1.11% of the float shorted and very low borrowing costs. Short sellers have been reducing positions since late March when SI peaked near 1.40%. The stock is down about 8% over the past month despite strong YTD performance (+22%). With an RSI approaching oversold levels, a healthy dividend yield near 4%, and analysts seeing 14% upside, the technical and fundamental picture looks reasonably constructive heading into earnings next week.

This is not financial advice. All data is subject to change.